Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p [Retraction]

Wang Q, Han J, Xu P, Jian X, Huang X, Liu D. Cancer Manag Res. 2021;13:1831—1841. We, the Editors and Publisher of the journal Cancer Management and Research, are retracting the published article. Since publication, concerns have been raised by a third party regarding the integrity of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Q, Han J, Xu P, Jian X, Huang X, Liu D
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/retraction-silencing-of-lncrna-snhg16-downregulates-cyclin-d1-ccnd1-to-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Wang Q, Han J, Xu P, Jian X, Huang X, Liu D. Cancer Manag Res. 2021;13:1831—1841. We, the Editors and Publisher of the journal Cancer Management and Research, are retracting the published article. Since publication, concerns have been raised by a third party regarding the integrity of the data in this article. Subsequently, the authors informed the Editor about the significant concerns regarding the reliability of the data presented in the article and so, have requested the retraction of the article. As the Editor and Publisher also have concerns about the integrity of the reported results, all parties have agreed to retract the article to ensure correction of the scholarly record. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
ISSN:1179-1322